Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Raltegravir, in combination with other anti-HIV medicines, maintained reductions in HIV-1 viral load and increased CD4 cell counts through 48 weeks of therapy in treatment-experienced adults

Merck Sharp & Dohme Limited
Posted on: 07 Feb 08

For more information:
www.msd-uk.co.uk

Editor's Details

Natalie Lewis
Reynolds-MacKenzie
www.msd-uk.co.uk
020 7031 4403
natalie@reynoldsmackenzie.com

Last updated on: 27/08/2010

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.